Depakote and Water retentionThis is a study of Water retention (Fluid Retention) among people who take Depakote. The study analyzes: the time on Depakote when people have Water retention, gender and age of these people, the severity of Water retention, how they recovered, and common conditions and drugs used besides Depakote. In total 27,713 Depakote users are studied. The study is created by eHealthMe based on reports from FDA and is updated regularly.
Do you have chronic disease and take multiple drugs? eHealthMe can monitor your drugs and notify you when there are serious drug reactions detected. Our original studies have been used on premier medical publications. The monitor will be personalized to your gender and age. Start now DepakoteDepakote has active ingredients of divalproex sodium. It is used in bipolar disorder, bipolar i disorder, epilepsy, mood swings, seizures. Commonly reported side effects of Depakote include weight increased, convulsion, fatigue, diabetes, nausea. Water retentionWater retention has been reported by people with high blood pressure, primary pulmonary hypertension, diabetes, type 2 diabetes, multiple sclerosis. On May, 16, 2013: 27,713 people reported to have side effects when taking Depakote. Among them, 31 people (0.11%) have Water Retention.  Time on Depakote when people have Water retention * :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years |
| Water retention | 0.00% | 66.67% | 0.00% | 16.67% | 16.67% | 0.00% | 0.00% |
Gender of people who have Water retention when taking Depakote * :
| Female | Male |
| Water retention | 51.61% | 48.39% |
Age of people who have Water retention when taking Depakote * :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ |
| Water retention | 0.00% | 0.00% | 0.00% | 4.76% | 23.81% | 33.33% | 38.10% | 0.00% |
Severity of Water retention when taking Depakote ** :
| least | moderate | severe | most severe |
| Water retention | 0.00% | 100.00% | 0.00% | 0.00% |
How people recovered from Water retention ** :
Top conditions involved for these people * :- Bipolar disorder (5 people, 16.13%)
- Bipolar i disorder (3 people, 9.68%)
- Diabetes mellitus (3 people, 9.68%)
- Sleep disorder (2 people, 6.45%)
- Depression (2 people, 6.45%)
Login or sign up (it's free) to view more results. Top co-used drugs for these people * :- Depakote er (8 people, 25.81%)
- Neurontin (4 people, 12.90%)
- Celexa (4 people, 12.90%)
- Zyprexa (4 people, 12.90%)
- Lipitor (4 people, 12.90%)
Login or sign up (it's free) to view more results. * Approximation only. Some reports may have incomplete information. ** Reports from social media are used. How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood. Next: check whether water retention is from a drug or a condition You can also:
On eHealthMe, Depakote (divalproex sodium) is often used for bipolar disorder. Find out below the conditions Depakote is used for, how effective it is, and any alternative drugs that you can use to treat those same conditions. What is Depakote used for and how effective is it: Other drugs that are used to treat the same conditions: Could it be a symptom from a condition: Browse Depakote side effects from A to Z:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z Browse Depakote drug interactions with drugs from A to Z:
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z Drugs in real world that are associated with: Comments from related studies: From this study (1 week ago): After taking Depakote for several years the side effects seemed to take over my life. I was then diagnosed with Fibromyalgia and have a lot of pain, confusion, and fatique. I fear that the drug did something to my body's chemistry. Reply From this study (1 week ago): On depakote ER for 3 months for CPS onset incident to mild TBI from close proximity high ordinance detonation (combat). Closed head concussion, secondary blast effect while in armored vehicle. Depakote caused negative behavioral swings, at worst resulting in mild rage response and high frustration.
Immediately upon initiation of transition to Vimpat notices improved behavioral results, lowered frustration. During transition increased perception difficulties, including perception lapses - looking for things right in front of me. Just finished transition, going to Vimpat only now. Reply From this study (2 weeks ago): Several Amoeba shaped, multi colored (shades of red, yellow, and pink), rashes appearing on all four extremities. Effects Extremities only. I.E. hands, forearms, bicep, thigh, lower legs. Reply From this study (3 weeks ago): I am suffering extreme fatigue. Reply Snood on May, 1, 2013: If you are a male and experiencing fatigue on Suboxone, then have your testosterone levels check-both free and bound testosterone Reply
Post a new comment OR Read more comments Recent related drug checks on eHealthMe:
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent drug studies on eHealthMe:
|
|